Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stewart, S. L.
Right arrow Articles by Patriotis, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stewart, S. L.
Right arrow Articles by Patriotis, C.
[Cancer Research 64, 8177-8183, November 15, 2004]
© 2004 American Association for Cancer Research


Regular Articles

Characterization of a Carcinogenesis Rat Model of Ovarian Preneoplasia and Neoplasia

Sherri L. Stewart1, Troy D. Querec1, Alexander R. Ochman1, Briana N. Gruver1, Rudi Bao1, James S. Babb2, Thang S. Wong1, Theodoros Koutroukides1, Aaron D. Pinnola1, Andres Klein-Szanto1, Thomas C. Hamilton1 and Christos Patriotis1

1 Medical Science Division and 2 Department of Biostatistics, Fox Chase Cancer Center, Philadelphia, Pennsylvania

Animal models of ovarian cancer are crucial for understanding the pathogenesis of the disease and for testing new treatment strategies. A model of ovarian carcinogenesis in the rat was modified and improved to yield ovarian preneoplastic and neoplastic lesions that pathogenetically resemble human ovarian cancer. A significantly lower dose (2 to 5 µg per ovary) of 7,12-dimethylbenz(a)anthracene (DMBA) was applied to the one ovary to maximally preserve its structural integrity. DMBA-induced mutagenesis was additionally combined with repetitive gonadotropin hormone stimulation to induce multiple cycles of active proliferation of the ovarian surface epithelium. Animals were treated in three arms of different doses of DMBA alone or followed by hormone administration. Comparison of the DMBA-treated ovaries with the contralateral control organs revealed the presence of epithelial cell origin lesions at morphologically distinct stages of preneoplasia and neoplasia. Their histopathology and path of dissemination to other organs are very similar to human ovarian cancer. Hormone cotreatment led to an increased lesion severity, indicating that gonadotropins may promote ovarian cancer progression. Point mutations in the Tp53 and Ki-Ras genes were detected that are also characteristic of human ovarian carcinomas. Additionally, an overexpression of estrogen and progesterone receptors was observed in preneoplastic and early neoplastic lesions, suggesting a role of these receptors in ovarian cancer development. These data indicate that this DMBA animal model gives rise to ovarian lesions that closely resemble human ovarian cancer and it is adequate for additional studies on the mechanisms of the disease and its clinical management.




This article has been cited by other articles:


Home page
Endocr. Rev.Home page
J.-H. Choi, A. S. T. Wong, H.-F. Huang, and P. C. K. Leung
Gonadotropins and Ovarian Cancer
Endocr. Rev., June 1, 2007; 28(4): 440 - 461.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
G. S. Gotfredson and W. J. Murdoch
A BRIEF COMMUNICATION: Morphologic Responses of the Mouse Ovarian Surface Epithelium to Ovulation and Steroid Hormonal Milieu
Experimental Biology and Medicine, February 1, 2007; 232(2): 277 - 280.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
A. Y. Ting, B. F. Kimler, C. J. Fabian, and B. K. Petroff
Characterization of a preclinical model of simultaneous breast and ovarian cancer progression
Carcinogenesis, January 1, 2007; 28(1): 130 - 135.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
W. J. Murdoch
Carcinogenic Potential of Ovulatory Genotoxicity
Biol Reprod, October 1, 2005; 73(4): 586 - 590.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
K. A. Crist, Z. Zhang, M. You, W. T. Gunning, P. B. Conran, V. E. Steele, and R. A. Lubet
Characterization of rat ovarian adenocarcinomas developed in response to direct instillation of 7,12-dimethylbenz[a]anthracene (DMBA) coated suture
Carcinogenesis, May 1, 2005; 26(5): 951 - 957.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2004 by the American Association for Cancer Research.